Pharmaceutical Company Lek Posts EUR 34 Milion Net Profits in 2001
Ljubljana, 27 February - 2001 was an even more successful business year for the Slovene pharmaceutical company Lek than the previous year, as the company posted net earnings of SIT 7.6 billion (EUR 34 million). This was a jump of almost 35 percent over the previous year, show the audited business result of the joint-stock company.
The rest of this news item is available to subscribers.
The news item consists of 1.224 characters (without spaces) or 254 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.